Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Bladder Dysfunction Reports
Published in: Current Bladder Dysfunction Reports 3/2014

01-09-2014 | Pediatric Bladder Dysfunction (SJ Hodges, Section Editor)

The Role of Bladder and Bowel Dysfunction (BBD) in Pediatric Urinary Tract Infections

Authors: Linda C. Lee, Martin A. Koyle

Published in: Current Bladder Dysfunction Reports | Issue 3/2014

Login to get access

Abstract

The child with lower urinary tract symptoms, in the absence of neurological abnormalities, represents an increasingly common source of referral to the pediatric urologist. Patients with lower urinary tract dysfunction are at increased risk of urinary tract infections (UTIs), which can be a potential source of expense, inconvenience, and even morbidity and renal impairment. Many of these patients present with concomitant bowel dysfunction in the form of constipation and encopresis. As a result, the term “bladder and bowel dysfunction” (BBD) has been introduced and refers to the close relationship of the bladder and bowel and their interrelated disturbances. An in-depth understanding of BBD and its role in recurrent UTI is the key to treatment and prevention of further morbidity in these patients. We present an updated review of the literature on BBD and UTIs in children, including its pathogenesis, evaluation, and management.
Literature
1.
Hinman F. Nonneurogenic neurogenic bladder (the Hinman syndrome)—15 years later. J Urol. 1986;136:769–77.PubMed
2.
Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol. 1998;160:1019–22.PubMedCrossRef
3.••
Austin PF et al. The standardization of terminology of lower urinary tract function in children and adolescents: update report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2014. doi:10.​1016/​j.​juro.​2014.​01.​110. Author's Note: Consistent use of terminology is important for future research and clinical practice. As such, it is crucial that pediatric urologists are familiar with this report.PubMedCentral
4.
Nevéus T et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006;176:314–24.PubMedCrossRef
5.
Yoshimura N, Chancellor MB. “Chapter 60: Physiology and Pharmacology of the Bladder and Urethra.” In: Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 10th ed. Philadelphia: Elsevier Saunders; 2012. p. 1786–833.
6.
Yeung C, Barker GM and Lackgren G. “Chapter 17: Pathophysiology of Bladder Dysfunction.” In: Gearhart J, Rink R, Mouriquand P, editors. Pediatric Urology. 2nd ed. Philadelphia: Elsevier Saunders; 2010. p. 353–65.
7.
Burgers R et al. Functional defecation disorders in children with lower urinary tract symptoms. J Urol. 2013;189:1886–91.PubMedCrossRef
8.
Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997;100:228–32.PubMedCrossRef
9.
Burgers R et al. Effect of rectal distention on lower urinary tract function in children. J Urol. 2010;184:1680–5.PubMedCrossRef
10.
O’Regan S, Yazbeck S, Schick E. Constipation, bladder instability, urinary tract infection syndrome. Clin Nephrol. 1985;23:152–4.PubMed
11.
Wald A, Chandra R, Chiponis D, Gabel S. Anorectal function and continence mechanisms in childhood encopresis. J Pediatr Gastroenterol Nutr. 1986;5:346–51.PubMedCrossRef
12.
Heyns CF. Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World J Urol. 2011;30:77–83.PubMedCrossRef
13.
Hellström A, Hanson E, Hansson S, Hjälmås K, Jodal U. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child. 1991;66:232–4.PubMedCentralPubMedCrossRef
14.
Van Batavia JP, Ahn JJ, Fast AM, Combs AJ, Glassberg KI. Prevalence of urinary tract infection and vesicoureteral reflux in children with lower urinary tract dysfunction. J Urol. 2013;190:1495–500.PubMedCrossRef
15.
Chen JJ, Mao W, Homayoon K, Steinhardt GF. A multivariate analysis of dysfunctional elimination syndrome, and its relationships with gender, urinary tract infection and vesicoureteral reflux in children. J Urol. 2004;171:1907–10.PubMedCrossRef
16.
Shaikh N et al. Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life? Pediatrics. 2003;112:1134–7.PubMedCrossRef
17.
Peters CA et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J Urol. 2010;184:1134–44.PubMedCrossRef
18.
Zink S, Freitag CM, von Gontard A. Behavioral comorbidity differs in subtypes of enuresis and urinary incontinence. J Urol. 2008;179:295–8.PubMedCrossRef
19.
Mazzola BL, Von Vigier RO, Marchand S, Tonz M, Blanchetti MG. Behavioral and functional abnormalities linked to recurrent urinary tract infections in girls. J Nephrol. 2003;16:133–6.PubMed
20.
Von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185:1432–7.CrossRef
21.••
Burgers RE et al. Management of functional constipation in children with lower urinary tract symptoms: report from the Standardization Committee of the International Children’s Continence Society. J Urol. 2013;190:29–36. Author’s Note: This an excellent reference for those who are evaluating and treating constipation and/or encopresis.PubMedCrossRef
22.
Farhat W et al. The dysfunctional voiding scoring system: quantitative standardization of dysfunctional voiding symptoms in children. J Urol. 2000;164:1011–5.PubMedCrossRef
23.
Farhat W, McLorie G, O’Reilly S, Khoury A, Bagli D. Reliability of the pediatric dysfunctional voiding symptom score in monitoring response to behavioral modification. Can J Urol. 2001;8:1401–5.PubMed
24.
25.
Glassberg KI, Combs AJ, Horowitz M. Nonneurogenic voiding disorders in children and adolescents: clinical and videourodynamic findings in 4 specific conditions. J Urol. 2010;184:2123–7.PubMedCrossRef
26.
Joensson IM, Siggaard C, Rittig S, Hagstroem S, Djurhuus JC. Transabdominal ultrasound of rectum as a diagnostic tool in childhood constipation. J Urol. 2008;179:1997–2002.PubMedCrossRef
27.
Tarcan T et al. The value of sacral skin lesions in predicting occult spinal dysraphism in children with voiding dysfunction and normal neurological examination. J Pediatr Urol. 2012;8:55–8.PubMedCrossRef
28.
Lavallée LT, Leonard MP, Dubois C, Guerra LA. Urodynamic testing—is it a useful tool in the management of children with cutaneous stigmata of occult spinal dysraphism? J Urol. 2013;189:678–83.PubMedCrossRef
29.
30.
Grin P, Kowalewska P, Alhazzan W, Fox-Robichaud A. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20:6607–14.PubMed
31.
Mugie SM, Di Lorenzo C, Benninga MA. Constipation in childhood. Nat Rev Gastroenterol Hepatol. 2011;8:502–11.PubMedCrossRef
32.
Bekkali N-L-H et al. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Pediatrics. 2009;124:e1108–15.PubMedCrossRef
33.
34.
Vasconcelos M et al. Voiding dysfunction in children. Pelvic-floor exercises or biofeedback therapy: a randomized study. Pediatr Nephrol. 2006;21:1858–64.PubMedCrossRef
35.•
Desantis DJ, Leonard MP, Preston MA, Barrowman NJ, Guerra LA. Effectiveness of biofeedback for dysfunctional elimination syndrome in pediatrics: a systematic review. J Pediatr Urol. 2011;7:342–8. Author’s note: This paper provides a systematic review of biofeedback as a non-invasive therapy for BBD. Nevertheless, the authors acknowledge the need for RCTs and better quality research on this topic.PubMedCrossRef
36.
Austin PF. The role of alpha blockers in children with dysfunctional voiding. Sci World J. 2009;9:880–3.CrossRef
37.
Austin P et al. Alpha-adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction. J Urol. 1999;162:1064–7.PubMedCrossRef
38.
Cain M, Wu S, Austin P, Herndon C, Rink R. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol. 2003;170:1514–5.PubMedCrossRef
39.
Donohoe JM, Combs AJ, Glassberg KI. Primary bladder neck dysfunction in children and adolescents II: results of treatment with α-adrenergic antagonists. J Urol. 2005;173:212–6.PubMedCrossRef
40.
Kramer S, Rathbun S, Elkins D, Karnes R, Husmann D. Double-blind placebo controlled study of α-adrenergic receptor antagonists (DOXAZOSIN) for treatment of voiding dysfunction in the pediatric population. J Urol. 2005;173:2121–4.PubMedCrossRef
41.
Yucel S et al. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study. J Urol. 2005;174:1612–5.PubMedCrossRef
42.
Goessl C et al. Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology. 2000;55:414–8.PubMedCrossRef
43.
Hjälmås K, Hellström A-L, Mogren K, Läckgren G, Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. BJU Int. 2001;87:569–74.PubMedCrossRef
44.
Raes A et al. Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder. Eur Urol. 2004;45:240–4.PubMedCrossRef
45.
Ayan S et al. Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children. BJU Int. 2005;96:411–4.PubMedCrossRef
46.
Kilic N, Balkan E, Akgoz S, Sen N, Dogruyol H. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability. Int J Urol. 2006;13:105–8.PubMed
47.
Bolduc S et al. The use of tolterodine in children after oxybutynin failure. BJU Int. 2003;91:398–401.PubMedCrossRef
48.
Mungding M, Wessells H, Thornberry B, Riden D. Use of tolterodine in children with dysfunctional voiding: an initial report. J Urol. 2001;165:926–8.CrossRef
49.
Babu R. Effectiveness of tolterodine in non-neurogenic voiding dysfunction. Indian Pediatr. 2006;43:980.PubMed
50.
Ayan S, Topsakal K, Gokce G, Gultekin EY. Efficacy of combined anticholinergic treatment and behavioral modification as a first line treatment for nonneurogenic and nonanatomical voiding dysfunction in children: a randomized controlled trial. J Urol. 2007;177:2325–9.PubMedCrossRef
51.
Mangera A et al. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol. 2014;65:981–90.PubMedCrossRef
52.
Steinhardt GF, Naseer S, Cruz OA. Botulinum toxin: novel treatment for dramatic urethral dilatation associated with dysfunctional voiding. J Urol. 1997;158:190–1.PubMedCrossRef
53.
Radojicic ZI, Perovic SV, Milic NM. Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J Urol. 2006;176:332–6.PubMedCrossRef
54.
55.
Franco I, Landau-Dyer L, Isom-Batz G, Collett T, Reda EF. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children. J Urol. 2007;178:1775–80.PubMedCrossRef
56.
Pohl HG et al. The outcome of voiding dysfunction managed with clean intermittent catheterization in neurologically and anatomically normal children. BJU Int. 2002;89:923–7.PubMedCrossRef
57.
Silay MS et al. Twelve-year experience with Hinman-Allen syndrome at a single center. Urology. 2011;78:1397–401.PubMedCrossRef
58.
Handel LN, Barqawi A, Checa G, Furness III PD, Koyle MA. Males with Down’s syndrome and nonneurogenic neurogenic bladder. J. Urol. 2003; 169:646–649.
59.
60.
Chait P, Shandling B, Richards H, Connolly B. Fecal incontinence in children: treatment with percutaneous cecostomy tube placement—a prospective study. Radiology. 1997;203:621–4.PubMedCrossRef
61.
Christison-Lagay ER et al. Antegrade colonic enemas and intestinal diversion are highly effective in the management of children with intractable constipation. J Pediatr Surg. 2010;45:213–9.PubMedCrossRef
62.
Vesna ZD, Milica L, Stanković I, Marina V, Andjelka S. The evaluation of combined standard urotherapy, abdominal and pelvic floor retraining in children with dysfunctional voiding. J Pediatr Urol. 2011;7:336–41.PubMedCrossRef
63.
Yang SS-D, Chiang I-N, Lin C-D, Chang S-J. Advances in non-surgical treatments for urinary tract infections in children. World J Urol. 2011;30:69–75.PubMedCrossRef
64.
Rasquin A et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology. 2006;130:1527–37.PubMedCrossRef
Metadata
Title
The Role of Bladder and Bowel Dysfunction (BBD) in Pediatric Urinary Tract Infections
Authors
Linda C. Lee
Martin A. Koyle
Publication date
01-09-2014
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 3/2014
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-014-0240-0

Other articles of this Issue 3/2014

Current Bladder Dysfunction Reports 3/2014 Go to the issue

Post-Prostatectomy and Acquired Voiding Dysfunction (V Tse, Section Editor)

Management of Bladder Neck Stenosis Secondary to Radical Prostatectomy or Radiation Treatment

Pediatric Bladder Dysfunction (SJ Hodges, Section Editor)

Update on Overactive Bladder in Children—Current Bladder Dysfunction Reports 2012, 7:27–32

Post-Prostatectomy and Acquired Voiding Dysfunction (V Tse, Section Editor)

Management of Lower Urinary Tract Dysfunction in Parkinson’s Disease: a Review of Recent Treatment Options

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Urethritis in Women—Considerations Beyond Urinary Tract Infection

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Post-Radiation Cystitis: Current Treatments

Inflammatory/Infectious Bladder Conditions (S Mourad, Section Editor)

Diagnosis and Management of Fungal Urinary Tract Infections